文献速递脑血管病神经重症与神经感染

甲基苯丙胺相关脑出血的临床特征与结局

Clinical characteristics and outcomes of methamphetamine-associated intracerebral hemorrhage.
PubMed 文献 · Neurology · 2019-05-29

该回顾性研究比较了甲基苯丙胺阳性和阴性自发性脑出血患者的临床特征与结局。甲基苯丙胺阳性患者更年轻、舒张压和平均动脉压更高、住院和ICU时间更长、需更多天静脉降压药、更多皮层下出血,但出院时mRS功能变化更大;多因素分析中甲基苯丙胺使用预测住院和ICU时长,但不预测不良结局(mRS 4-6)。

要点

  • 甲基苯丙胺阳性脑出血患者比阴性者年轻约15岁(52 vs 67岁)。
  • 阳性组住院和ICU时间更长,需更多天静脉降压治疗。
  • 甲基苯丙胺使用不预测出院时不良功能结局(mRS 4-6)。

核心结论

  • 甲基苯丙胺使用与脑出血发病年龄更早、住院时间更长和功能能力变化更大相关,但不预测不良结局。

研究设计与样本

  • 回顾性分析2013年1月至2016年12月3年间诊断为自发性非创伤性脑出血的患者,比较甲基苯丙胺毒理学阳性与阴性者的 demographics、临床指标和结局。

主要发现

  • 甲基苯丙胺阳性脑出血患者年龄52岁 vs 阴性67岁(p < 0.001)。
  • 阳性组舒张压115 vs 101(p = 0.003),平均动脉压144 vs 129(p = 0.01)。
  • 阳性组住院18天 vs 8天(p < 0.001),ICU停留10天 vs 5天(p < 0.001)。
  • 阳性组需静脉降压药5天 vs 3天(p = 0.02),皮层下出血比例63% vs 46%(p = 0.05)。
  • 阳性组病前mRS更好(p < 0.001),出院时mRS功能能力变化更大(p = 0.001)。

关键数值与推荐

  • 多因素分析中甲基苯丙胺使用不预测不良结局(mRS 4-6)。

临床怎么用

  • 对年轻自发性脑出血患者应考虑甲基苯丙胺暴露可能,并关注血压管理和延长住院资源的准备。

局限性

  • 回顾性研究设计可能引入选择和信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the clinical characteristics and outcomes of primary intracerebral hemorrhage (ICH) with and without methamphetamine exposure. METHODS: We performed a retrospective analysis of patients diagnosed with spontaneous, nontraumatic ICH over a 3-year period between January 2013 and December 2016. Demographics, clinical measures, and outcomes were compared between ICH patients with positive methamphetamine toxicology tests vs those with negative methamphetamine toxicology tests. RESULTS: Methamphetamine-positive ICH patients were younger than methamphetamine-negative ICH patients (52 vs 67 years, p < 0.001). Patients with methamphetamine-positive ICH had higher diastolic blood pressure (115 vs 101, p = 0.003), higher mean arterial pressure (144 vs 129, p = 0.01), longer lengths of hospital (18 vs 8 days, p < 0.001) and intensive care unit (ICU) stay (10 vs 5 days, p < 0.001), required more days of IV antihypertensive medications (5 vs 3 days, p = 0.02), and had more subcortical hemorrhages (63% vs 46%, p = 0.05). The methamphetamine-positive group had better premorbid modified Rankin Scale (mRS) scores (p < 0.001) and a greater change in functional ability as measured by mRS at the time of hospital discharge (p = 0.001). In multivariate analyses, methamphetamine use predicted both hospital length of stay (risk ratio [RR] 1.54, confidence interval [CI] 1.39-1.70, p < 0.001) and ICU length of stay (RR 1.36, CI 1.18-1.56, p < 0.001), but did not predict poor outcome (mRS 4-6). CONCLUSIONS: Methamphetamine use is associated with earlier age at onset of ICH, longer hospital stays, and greater change in functional ability, but did not predict outcome.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Swor DE, Maas MB, Walia SS, et al. Clinical characteristics and outcomes of methamphetamine-associated intracerebral hemorrhage. Neurology. 2019. PMID: 31142634. doi:10.1212/WNL.0000000000007666

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。